A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
Clinical trial NCT03761095 · COMPLETED
Trial details
- NCT number
- NCT03761095
- Sponsor
- PTC Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-13
- Primary completion
- 2024-02-05
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.